Technical Analysis for RAPT - RAPT Therapeutics, Inc.

Grade Last Price % Change Price Change
C 21.91 0.00% 0.00
RAPT closed unchanged on Wednesday, May 5, 2021, on 63 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat
Historical RAPT trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction -0.59%
NR7 Range Contraction -0.59%
Shooting Star Candlestick Bearish -0.14%
Lizard Bearish Bearish Day Trade Setup -0.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.23%
Inside Day Range Contraction -2.23%
Up 3 Days in a Row Strength -2.23%
Up 4 Days in a Row Strength -2.23%
20 DMA Support Bullish -0.09%
Doji - Bearish? Reversal -0.09%
Older End-of-Day Signals for RAPT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 7 hours ago
Up 1% about 7 hours ago
60 Minute Opening Range Breakout about 7 hours ago
10 DMA Resistance about 9 hours ago
10 DMA Support about 9 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

RAPT Therapeutics, Inc. Description

RAPT Therapeutics, Inc., a clinical stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. The company develops small molecules that are designed to modulate the critical immune responses underlying these diseases. Its lead oncology drug candidate is FLX475 for the treatment of a range of tumors; and RPT193, a CCR4 antagonist for allergic inflammatory disease. The company is also pursuing a range of targets, including general control nonderepressible and hematopoietic progenitor kinase for the treatment of cancer. RAPT Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California. RAPT Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Immunology Diseases Treatment Of Cancer Pharmacy Inflammatory Disease Inflammatory Diseases Tumors Specialty Drugs Immune Response Small Molecule Therapies Bristol Myers Squibb

Is RAPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 41.86
52 Week Low 14.09
Average Volume 141,320
200-Day Moving Average 24.66
50-Day Moving Average 21.02
20-Day Moving Average 21.31
10-Day Moving Average 21.85
Average True Range 1.31
ADX 11.88
+DI 19.88
-DI 15.87
Chandelier Exit (Long, 3 ATRs ) 19.78
Chandelier Exit (Short, 3 ATRs ) 22.98
Upper Bollinger Band 22.90
Lower Bollinger Band 19.73
Percent B (%b) 0.69
BandWidth 14.88
MACD Line 0.20
MACD Signal Line 0.13
MACD Histogram 0.066
Fundamentals Value
Market Cap 538.01 Million
Num Shares 24.6 Million
EPS -1.89
Price-to-Earnings (P/E) Ratio -11.59
Price-to-Sales 111.36
Price-to-Book 4.27
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.29
Resistance 3 (R3) 23.28 22.81 23.06
Resistance 2 (R2) 22.81 22.46 22.82 22.98
Resistance 1 (R1) 22.36 22.24 22.59 22.37 22.91
Pivot Point 21.89 21.89 22.00 21.90 21.89
Support 1 (S1) 21.44 21.54 21.67 21.45 20.91
Support 2 (S2) 20.97 21.32 20.98 20.84
Support 3 (S3) 20.52 20.97 20.76
Support 4 (S4) 20.53